Appendix C
NIH List of Firms Excluded on the Grounds of Venture Capital Ownership*

FIRM NAME

Altus Biologics, Inc.

Applied Genetic Technologies Corp.

Arginox Pharmaceuticals

Argolyn Bioscience, Inc.

Arizeke Pharmaceuticals

Ascenta Therapeutics, Inc.

Aspect Medical Systems, Inc.

Biospect Inc./Predicant Biosciences

BrainCells, Inc.

Calypso Medical Technologies, Inc.

Cell Biosciences

Cengent Therapeutics, Inc.

CEPTYR, Inc.

Cerus Corporation

Chlorogen

CUMBRE, Inc.

Diversa Corp.

Encysive Pharmaceuticals

FivePrime Therapeutics

GlycoFi, Inc.

Gryphon Therapeutics, Inc.

*

These firms were submitted by NIH as an illustrative list of firms they believe were excluded.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 80
Appendix C NIH List of Firms Excluded on the Grounds of Venture Capital Ownership* FIRM NAME Altus Biologics, Inc. Applied Genetic Technologies Corp. Arginox Pharmaceuticals Argolyn Bioscience, Inc. Arizeke Pharmaceuticals Ascenta Therapeutics, Inc. Aspect Medical Systems, Inc. Biospect Inc./Predicant Biosciences BrainCells, Inc. Calypso Medical Technologies, Inc. Cell Biosciences Cengent Therapeutics, Inc. CEPTYR, Inc. Cerus Corporation Chlorogen CUMBRE, Inc. Diversa Corp. Encysive Pharmaceuticals FivePrime Therapeutics GlycoFi, Inc. Gryphon Therapeutics, Inc. *These firms were submitted by NIH as an illustrative list of firms they believe were excluded. 0

OCR for page 80
1 APPENDIX C Handylab Inc. IDM Pharma, Inc. Infigen, Inc. Inotek Pharmaceuticals Lincoln Technologies Macrogenics, Inc. MEMX Metabolon, Inc. MicroOptical Corporation MicroOptical Engineering Corporation Myomatrix Therapeutics NanoMix, Inc. NanoString Technologies, Inc. Natus Medical (BioLogics) Nephros Therapeutics, Inc. Neurogenetics, Inc. Norak Biosciences, Inc. Northwest Medical Physics Equipment Paratek Pharmaceuticals Peptx, Inc. Phenomix Corp. PTC Therapeutics, Inc. Saegis Pharmaceuticals Inc. Sentrx Surgical/Carbylan Biosurgery Sirtris Pharmaceuticals Threshold Pharmaceuticals, Inc. Transave, Inc. Traxtal, Inc. Trellis Bioscience Tularik, Inc. Vion Pharmaceuticals, Inc. Virxsys Corp. VisEn Medical, Inc. Yasoo Health, Inc.